Detalhe da pesquisa
1.
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers (Basel)
; 14(10)2022 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35626010
2.
Anti-cancer drugs-induced arterial injury: risk stratification, prevention, and treatment.
Med Oncol
; 36(8): 72, 2019 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292791